CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
spontaneous sputumother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02976714
NCT02976714N/ACompleted

Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis

University Hospital, Montpellier·interventional·Posted Nov 29, 2016·Updated Apr 2, 2026

In Brief

A clinical study evaluating spontaneous sputum for Cystic Fibrosis. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The general aims of this project are (i) to identify predictive epigenetic biomarkers of lung disease severity in Cystic Fibrosis, (ii) to characterize a non-invasive cellular model, spontaneous sputum, for the analysis of these epigenetic biomarkers, (iii) to analyze the variations in DNA methylation for a same patient over time.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 29, 2016
Enrollment StartDec 12, 2016
Primary CompletionJul 13, 2021
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 9.6 years ago

Interventions

spontaneous sputumother

CF patients carry a spontaneous sputum that is made in the context of bronchial drainage sessions conducted as part of usual care (inclusion, 6 months, 12 months, 18 months). The collection of spontaneous sputum is carried out within the bronchial drainage sessions, which are routinely performed at each visit. The spontaneous sputum is collected in a sterile container. In order not to contaminate the sputum with buccal epithelial cells will be asked patients to rinse the mouth before expectorate.